Del i serien Respiratory Pharmacology and Pharmacotherapy

Clinical and Biological Basis of Lung Cancer Prevention

Inbunden, Engelska, 1997

AvYves Martinet,etc.,Y. Martinet,Yves Martinet,F.R. Hirsch

1 149 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Produktinformation

Utgivningsdatum1997-12-18
Mått165 x 235 x undefined mm
FormatInbunden
SpråkEngelska
SerieRespiratory Pharmacology and Pharmacotherapy
Antal sidor348
FörlagBirkhauser Verlag AG
ISBN9783764357788

Tillhör följande kategorier

Prevention and early detection of lung cancer - clinical aspects, F.R. Hirsch, J.L. Mulshine; smoking prevention and cessation, P. Tonnesen et al; clinical pharmacology of vitamin A and retinoids, U. Pastorino, F. Formelli; easy lung cancer detection, E. Brambilla; molecular abnormalities in the sequential development of lung carcinoma, I.I. Wistuba, A.F. Gazdar; application of In Situ PCR and In Situ hybridization to the characterization of lung cancers, A. Martinez; tumour stroma formation in lung cancer, J-M. Vignaud et al; tumour angiogenesis - basis for new prognostic factors and new anticancer therapies, D. Belotti, V. Castronovo; cell cycle regulators and mechanisms of growth control evasion in lung cancer, I.E. Schauer, R.A. Sclafani; molecular genetics of lung cancer, X.W. Wang et al; neuropeptides, signal transduction and small cell lung cancer, M.J. Seckl, E. Rozengurt; In Vitro analysis of bombesin/gastrin-releasing peptide receptor (bb2) ligand binding and G-protein coupling, G.S. Kroog et al; DNA methylation changes in lung cancer, S.M. Hanash et al; K-ras mutations as molecular markers of lung cancer, D.R. Jacobson; seep lung adenomatosis - a model of virally induced lung cancer, C. Leroux et al; retinoid acid receptor beta - an exploration of its role in lung cancer suppression and its potential in cancer prevention, A. Toulouse et al; cytochrome P450 polymorphisms - risk factors for lung cancer? S. Benhamou, C. Bonaiti-Pellie; glutathione S-tranferases and lung cancer risk, J. Seidegard; the p53 tumour suppressor gene in lung cancer - from molecular to serological diagnosis, T. Soussi et al; endoscopic localization of preneoplastic lung lesions, S. Lam, C.E. MacAulay; antigen retrieval improves hnRNP A2/Bi immunohistological localization in premalignant lesions of the lung, M.S. Tockman et al; molecular pathological mechanisms in NSCLC and the assessment of individuals with high risk of developing lung cancer, J.K. Field et al; chemoprevention of lung cancer, U. Pastorino; regional delivery of retinoids - a new approach to early lung cancer intervention, J.L. Mulshine et al; natural inhibitors of carcinogenesis, H. Fujiki et al; gene delivery to airways, C. Schatz, A. Pavirani; lung cancer prevention - the point of a public health epidemiologist, A.J. Sasco; biomarkers as intermediate endpoints in chemoprevention trials - biological basis of lung cancer prevention, V.A. Papadimitrakopoulou, W.K. Hong; biological tools for mass screening, N. Martinet, M. Hogan; optimization of the use of biological samples for the perspective evaluation of preneoplastic lesions, R. Gemmil et al.